BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10380930)

  • 1. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors.
    Wang JH; Smolyar A; Tan K; Liu JH; Kim M; Sun ZY; Wagner G; Reinherz EL
    Cell; 1999 Jun; 97(6):791-803. PubMed ID: 10380930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of the CD2-binding domain of CD58 (lymphocyte function-associated antigen 3) at 1.8-A resolution.
    Ikemizu S; Sparks LM; van der Merwe PA; Harlos K; Stuart DI; Jones EY; Davis SJ
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4289-94. PubMed ID: 10200255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topology of the CD2-CD48 cell-adhesion molecule complex: implications for antigen recognition by T cells.
    van der Merwe PA; McNamee PN; Davies EA; Barclay AN; Davis SJ
    Curr Biol; 1995 Jan; 5(1):74-84. PubMed ID: 7697352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Costimulatory Function of Cd58/Cd2 Interaction in Adaptive Humoral Immunity in a Zebrafish Model.
    Shao T; Shi W; Zheng JY; Xu XX; Lin AF; Xiang LX; Shao JZ
    Front Immunol; 2018; 9():1204. PubMed ID: 29904386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural biology of the cell adhesion protein CD2: from molecular recognition to protein folding and design.
    Wilkins AL; Yang W; Yang JJ
    Curr Protein Pept Sci; 2003 Oct; 4(5):367-73. PubMed ID: 14529530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction between human CD2 and CD58 involves the major beta sheet surface of each of their respective adhesion domains.
    Arulanandam AR; Kister A; McGregor MJ; Wyss DF; Wagner G; Reinherz EL
    J Exp Med; 1994 Nov; 180(5):1861-71. PubMed ID: 7525842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Porcine CD58: cDNA cloning and molecular dissection of the porcine CD58-human CD2 interface.
    Brossay A; Hubé F; Moreau T; Bardos P; Watier H
    Biochem Biophys Res Commun; 2003 Oct; 309(4):992-8. PubMed ID: 13679072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigating cyclic peptides inhibiting CD2-CD58 interactions through molecular dynamics and molecular docking methods.
    Leherte L; Petit A; Jacquemin D; Vercauteren DP; Laurent AD
    J Comput Aided Mol Des; 2018 Nov; 32(11):1295-1313. PubMed ID: 30368623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The contribution of conformational adjustments and long-range electrostatic forces to the CD2/CD58 interaction.
    Kearney A; Avramovic A; Castro MA; Carmo AM; Davis SJ; van der Merwe PA
    J Biol Chem; 2007 May; 282(18):13160-6. PubMed ID: 17344209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A computer model of the LFA-3/CD2 complex.
    Nuallain BO; Grant GH
    Biochem Soc Trans; 1998 Feb; 26(1):S44. PubMed ID: 10909802
    [No Abstract]   [Full Text] [Related]  

  • 11. The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C" face of the human CD2 adhesion domain.
    Arulanandam AR; Withka JM; Wyss DF; Wagner G; Kister A; Pallai P; Recny MA; Reinherz EL
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11613-7. PubMed ID: 7505442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunosuppression by co-stimulatory molecules: inhibition of CD2-CD48/CD58 interaction by peptides from CD2 to suppress progression of collagen-induced arthritis in mice.
    Gokhale A; Kanthala S; Latendresse J; Taneja V; Satyanarayanajois S
    Chem Biol Drug Des; 2013 Jul; 82(1):106-18. PubMed ID: 23530775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amino acid residues required for binding of lymphocyte function-associated antigen 3 (CD58) to its counter-receptor CD2.
    Osborn L; Day ES; Miller GT; Karpusas M; Tizard R; Meuer SC; Hochman PS
    J Exp Med; 1995 Jan; 181(1):429-34. PubMed ID: 7528777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide from the beta-strand region of CD2 protein that inhibits cell adhesion and suppresses arthritis in a mouse model.
    Satyanarayanajois SD; Büyüktimkin B; Gokhale A; Ronald S; Siahaan TJ; Latendresse JR
    Chem Biol Drug Des; 2010 Sep; 76(3):234-44. PubMed ID: 20572813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of salt bridges on the equilibrium binding and adhesion of human CD2 and CD58.
    Bayas MV; Kearney A; Avramovic A; van der Merwe PA; Leckband DE
    J Biol Chem; 2007 Feb; 282(8):5589-96. PubMed ID: 17172599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adhesive bond dynamics in contacts between T lymphocytes and glass-supported planar bilayers reconstituted with the immunoglobulin-related adhesion molecule CD58.
    Dustin ML
    J Biol Chem; 1997 Jun; 272(25):15782-8. PubMed ID: 9188475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based identification of inhibitors disrupting the CD2-CD58 interactions.
    Tripathi N; Leherte L; Vercauteren DP; Laurent AD
    J Comput Aided Mol Des; 2021 Mar; 35(3):337-353. PubMed ID: 33532888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutational analysis of the CD2/CD58 interaction: the binding site for CD58 lies on one face of the first domain of human CD2.
    Somoza C; Driscoll PC; Cyster JG; Williams AF
    J Exp Med; 1993 Aug; 178(2):549-58. PubMed ID: 7688025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 A resolution.
    Bodian DL; Jones EY; Harlos K; Stuart DI; Davis SJ
    Structure; 1994 Aug; 2(8):755-66. PubMed ID: 7994575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59.
    van der Merwe PA; Barclay AN; Mason DW; Davies EA; Morgan BP; Tone M; Krishnam AK; Ianelli C; Davis SJ
    Biochemistry; 1994 Aug; 33(33):10149-60. PubMed ID: 7520278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.